Evercare Hospital Dhaka, the first JCI-accredited hospital in Bangladesh, announced at a press meet that they have successfully completed their 50th bone marrow transplant. With this, they now have a record of conducting the highest number of allogeneic BMTs in the country.
With a dedicated BMT unit and a leukemia unit, Evercare Hospital Dhaka is fully equipped to tackle different kinds of leukemia using autologous and allogeneic BMT with full match and half match (Haplo). Furthermore, the hospital has a stem cell processing lab; a Cryopreservation facility; outpatient and inpatient procedure facility; an in-house molecular diagnostic facility which provides fast and accurate diagnosis; BMT beds with central oxygen supply, HEPA Filter and a system for reverse osmosis water purification. It has a molecular lab which uses state-of-the-art technology of Flow Cytometry to diagnose the specific type of cancer. Services like subtyping, FLAER-based PNH, immune-histochemistry and PET-scan are available to make a quick and correct assessment of the patient’s condition.
Early diagnosis and planning of BMT procedures is crucial to the treatment of leukemia. Therefore, topnotch treatment planning tests like MRD and IHC tests are used to monitor the effectiveness of the treatment, and adapt for necessary changes.
Dr. Abu Jafar Mohammed Saleh, Coordinator & Senior Consultant, Hematology & Stem Cell Transplant, Evercare Hospital Dhaka, said, “BMT is a very risky procedure that comes with a lot of challenges. Prior to this development in Evercare Hospital, there were limited treatment for leukemia in the country. Hence, we are pleased to have been able to conduct this procedure in our hospital with success. We have a vision of providing comprehensive medical support to the people of Bangladesh. The expansion of our BMT unit is therefore a step forward in this regard. We currently have the utmost confidence and support from our clientele, and we wish to continue working with our best efforts in order to see this center become one of the best in this subcontinent.”
Dr Ratnadeep Chaskar, CEO & MD, Evercare Hospital Dhaka, said, “We are the first private hospital in the country to bring the advanced equipment required for BMT. With a fully equipped leukemia unit, BMT unit and the treatment planning processes, we hope to help more patients who are fighting the painful fear of losing their lives to cancer.”
Dr. Arif Mahmud, Deputy Director of Medical Services, Evercare Hospital Dhaka, said, “We have the best facilities for BMT treatment in Evercare Hospital Dhaka. Due to this development, patients don’t need to seek BMT treatment abroad anymore. It is much more cost-effective to do it in the country, and our success rates are as good as developed countries.”
About the Evercare Group
The Evercare Group believes access to healthcare is a fundamental right and invests in emerging markets to bring private, quality driven healthcare to meet the needs of local people.
Evercare has responded to a global challenge to ensure well-being at all ages is provided to those living in emerging markets as a pillar to support sustainable economic development. With this the Group is leading the way in transforming the traditional healthcare model through its integrated cross-continents platform, its impact driven model and quality driven hospitals.
The Evercare Group operates as an integrated healthcare delivery platform in emerging markets across Africa and South Asia, including India, Pakistan, Bangladesh, Kenya and Nigeria.
The Group’s portfolio includes 30 hospitals with 3445 beds, 16 clinics, 82 diagnostics centres and two brownfield assets spread over 6 countries. Evercare is proud to be the most diverse healthcare group in the countries it operates in with 11,000 caregivers working together to develop a systemic healthcare change in emerging markets.
Evercare is wholly owned by the Evercare Health Funds, a US $1bn emerging markets healthcare fund managed by The Rise Funds, the impact investment platform of global alternative asset manager TPG. The Evercare Health Fund is comprised of the world’s leading development finance institutions and other impact investors around the world.